Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

IBEX Sees FY2026 Sales $590.000M-$610.000M vs $544.090M Est

Author: Benzinga Newsdesk | September 11, 2025 04:07pm
IBEX (NASDAQ:IBEX) sees FY2026 sales of $590.000 million-$610.000 million vs $544.090 million analyst estimate.

Posted In: IBEX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist